Cargando…
Multifunctional CRISPR-Cas9 with engineered immunosilenced human T cell epitopes
The CRISPR-Cas9 system has raised hopes for developing personalized gene therapies for complex diseases. Its application for genetic and epigenetic therapies in humans raises concerns over immunogenicity of the bacterially derived Cas9 protein. Here we detect antibodies to Streptococcus pyogenes Cas...
Autores principales: | Ferdosi, Shayesteh R., Ewaisha, Radwa, Moghadam, Farzaneh, Krishna, Sri, Park, Jin G., Ebrahimkhani, Mo R., Kiani, Samira, Anderson, Karen S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6478683/ https://www.ncbi.nlm.nih.gov/pubmed/31015529 http://dx.doi.org/10.1038/s41467-019-09693-x |
Ejemplares similares
-
Immunogenicity of CRISPR therapeutics—Critical considerations for clinical translation
por: Ewaisha, Radwa, et al.
Publicado: (2023) -
Synthetic immunomodulation with a CRISPR super-repressor in vivo
por: Moghadam, Farzaneh, et al.
Publicado: (2020) -
Immunosilencing peptides by stereochemical inversion and sequence reversal: retro-D-peptides
por: Arranz-Gibert, Pol, et al.
Publicado: (2018) -
Tunable and Multifunctional Eukaryotic Transcription
Factors Based on CRISPR/Cas
por: Farzadfard, Fahim, et al.
Publicado: (2013) -
Serum Immune Profiling for Early Detection of Cervical Disease
por: Ewaisha, Radwa, et al.
Publicado: (2017)